Year<\/p><\/td> | Primary care net ingredient cost2<\/sup> £k<\/p><\/td>Secondary care cost3<\/sup> £k<\/p><\/td>Total cost £k<\/p><\/td><\/tr> | 2005<\/p><\/td> | 24,633.2<\/p><\/td> | 5,491.3<\/p><\/td> | 30,124.5<\/p><\/td><\/tr> | 2006<\/p><\/td> | 33,367.9<\/p><\/td> | 6,007.9<\/p><\/td> | 39,375.8<\/p><\/td><\/tr> | 2007<\/p><\/td> | 46,557.3<\/p><\/td> | 6,789.5<\/p><\/td> | 53,346.8<\/p><\/td><\/tr> | 2008<\/p><\/td> | 52,839.3<\/p><\/td> | 6,879.3<\/p><\/td> | 59,718.6<\/p><\/td><\/tr> | 2009<\/p><\/td> | 55,000.9<\/p><\/td> | 6,072.4<\/p><\/td> | 61,073.3<\/p><\/td><\/tr> | 2010<\/p><\/td> | 57,160.8<\/p><\/td> | 5,353.9<\/p><\/td> | 62,514.7<\/p><\/td><\/tr> | 2011<\/p><\/td> | 46,968.0<\/p><\/td> | 5,069.9<\/p><\/td> | 52,037.9<\/p><\/td><\/tr> | 2012<\/p><\/td> | 44,828.6<\/p><\/td> | 5,831.6<\/p><\/td> | 50,660.1<\/p><\/td><\/tr> | 2013<\/p><\/td> | 81,221.7<\/p><\/td> | 6,799.1<\/p><\/td> | 88,020.7<\/p><\/td><\/tr> | 2014<\/p><\/td> | 66,409.4<\/p><\/td> | 7,273.1<\/p><\/td> | 73,682.6<\/p><\/td><\/tr> | 2015<\/p><\/td> | 55,886.6<\/p><\/td> | 7,423.8<\/p><\/td> | 63,310.5<\/p><\/td><\/tr><\/tbody><\/table> Source: Prescription Cost Analysis and Hospital Pharmacy Audit Index © IMS HEALTH 2016 provided by NHS Digital<\/p> 1<\/sup> Includes alprazolam, chlordiazepoxide hydrochloride, clobazam, clonazepam, diazepam, flurazepam hydrochloride, loprazolam mesilate, lorazepam, lormetazepam, midazolam hydrochloride, midazolam maleate, nitrazepam, oxazepam, temazepam.<\/p>2<\/sup> Net ingredient cost is the basic cost of a drug. It does not take account of discounts, dispensing costs, fees or prescription charge income.<\/p>3 <\/sup>The cost of the medicines at NHS list price and not necessarily the price the hospital paid. May include drugs dispensed via hospital pharmacies to private patients in private wards within NHS hospitals.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4080", "label" : {"_value" : "Biography information for David Mowat"}
}
, "answeringMemberConstituency" : {"_value" : "Warrington South"}
, "answeringMemberPrinted" : {"_value" : "David Mowat"}
, "dateOfAnswer" : {"_value" : "2016-11-21", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2016-11-21T16:04:57.46Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2016-11-11", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Benzodiazepines"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, what the cost has been to the NHS of purchasing benzodiazepine in each of the last 10 years.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/545", "label" : {"_value" : "Biography information for Paul Flynn"}
}
, "tablingMemberConstituency" : {"_value" : "Newport West"}
, "tablingMemberPrinted" : [{"_value" : "Paul Flynn"}
], "uin" : "52696"}
, {"_about" : "http://data.parliament.uk/resources/634107", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/634107/answer", "answerText" : {"_value" : "The cost to the National Health Service of antidepressant drugs1<\/sup> prescribed and dispensed to patients in England is shown in the table.<\/p> <\/p> Year<\/p><\/td> | Primary care net ingredient cost2<\/sup> £k<\/p><\/td>Secondary care cost3<\/sup> £k<\/p><\/td>Total cost £k<\/p><\/td><\/tr> | 2005<\/p><\/td> | 338,546.7<\/p><\/td> | 16,907.9<\/p><\/td> | 355,454.6<\/p><\/td><\/tr> | 2006<\/p><\/td> | 291,511.4<\/p><\/td> | 14,112.4<\/p><\/td> | 305,623.8<\/p><\/td><\/tr> | 2007<\/p><\/td> | 276,107.6<\/p><\/td> | 12,496.8<\/p><\/td> | 288,604.4<\/p><\/td><\/tr> | 2008<\/p><\/td> | 247,355.1<\/p><\/td> | 11,360.6<\/p><\/td> | 258,715.7<\/p><\/td><\/tr> | 2009<\/p><\/td> | 230,062.9<\/p><\/td> | 9,816.0<\/p><\/td> | 239,878.8<\/p><\/td><\/tr> | 2010<\/p><\/td> | 220,372.8<\/p><\/td> | 8,223.5<\/p><\/td> | 228,596.3<\/p><\/td><\/tr> | 2011<\/p><\/td> | 270,177.2<\/p><\/td> | 7,819.4<\/p><\/td> | 277,996.6<\/p><\/td><\/tr> | 2012<\/p><\/td> | 211,145.4<\/p><\/td> | 7,453.6<\/p><\/td> | 218,599.0<\/p><\/td><\/tr> | 2013<\/p><\/td> | 282,121.6<\/p><\/td> | 8,708.9<\/p><\/td> | 290,830.5<\/p><\/td><\/tr> | 2014<\/p><\/td> | 265,003.7<\/p><\/td> | 8,901.4<\/p><\/td> | 273,905.1<\/p><\/td><\/tr> | 2015<\/p><\/td> | 284,745.6<\/p><\/td> | 9,232.8<\/p><\/td> | 293,978.4<\/p><\/td><\/tr><\/tbody><\/table> Source: Prescription Cost Analysis and Hospital Pharmacy Audit Index © IMS HEALTH 2016 provided by NHS Digital<\/p> 1<\/sup> For primary care, antidepressant drugs are defined as those listed in the British National Formulary (BNF) section 4.3 using the classification prior to edition 70. For secondary care, data on all drugs listed in BNF section 4.3 have been extracted from the Hospital Pharmacy Audit Index.<\/p>2<\/sup> Net ingredient cost is the basic cost of a drug. It does not take account of discounts, dispensing costs, fees or prescription charge income.<\/p>3 <\/sup>The cost of the medicines at NHS list price and not necessarily the price the hospital paid. May include drugs dispensed via hospital pharmacies to private patients in private wards within NHS hospitals.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4080", "label" : {"_value" : "Biography information for David Mowat"}
}
, "answeringMemberConstituency" : {"_value" : "Warrington South"}
, "answeringMemberPrinted" : {"_value" : "David Mowat"}
, "dateOfAnswer" : {"_value" : "2016-11-21", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2016-11-21T16:03:48.737Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2016-11-11", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Antidepressants"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, what the cost has been to the NHS of purchasing anti-depressants in each of the last 10 years.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/545", "label" : {"_value" : "Biography information for Paul Flynn"}
}
, "tablingMemberConstituency" : {"_value" : "Newport West"}
, "tablingMemberPrinted" : [{"_value" : "Paul Flynn"}
], "uin" : "52697"}
, {"_about" : "http://data.parliament.uk/resources/631245", "AnsweringBody" : [{"_value" : "Department for Transport"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/631245/answer", "answerText" : {"_value" : "The Department expects to publish the research report in spring 2017.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/3996", "label" : {"_value" : "Biography information for Andrew Jones"}
}
, "answeringMemberConstituency" : {"_value" : "Harrogate and Knaresborough"}
, "answeringMemberPrinted" : {"_value" : "Andrew Jones"}
, "dateOfAnswer" : {"_value" : "2016-11-18", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2016-11-18T08:55:36.757Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "27"}
, "answeringDeptShortName" : {"_value" : "Transport"}
, "answeringDeptSortName" : {"_value" : "Transport"}
, "date" : {"_value" : "2016-11-07", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Driving under Influence: Drugs"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Transport, with reference to the Answer of 26 May 2016 to Question 37602, when in 2017 he plans to publish the contracted researcher's findings on the effect and impact on road safety of the new section 5A offence.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/545", "label" : {"_value" : "Biography information for Paul Flynn"}
}
, "tablingMemberConstituency" : {"_value" : "Newport West"}
, "tablingMemberPrinted" : [{"_value" : "Paul Flynn"}
], "uin" : "52153"}
, {"_about" : "http://data.parliament.uk/resources/627256", "AnsweringBody" : [{"_value" : "Department for Exiting the European Union"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/627256/answer", "answerText" : {"_value" : " The Government has consistently said it will comply with all the constitutional and legal obligations that apply to the deal that we will negotiate with the EU. However, the Government's position is that the Ponsonby Rule (as codified in the Constitutional Reform and Governance Act 2010) is not relevant to the invocation of Article 50.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/1502", "label" : {"_value" : "Biography information for Mr David Jones"}
}
, "answeringMemberConstituency" : {"_value" : "Clwyd West"}
, "answeringMemberPrinted" : {"_value" : "Mr David Jones"}
, "dateOfAnswer" : {"_value" : "2016-11-07", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2016-11-07T12:03:33.15Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "203"}
, "answeringDeptShortName" : {"_value" : "Exiting the European Union"}
, "answeringDeptSortName" : {"_value" : "Exiting the European Union"}
, "date" : {"_value" : "2016-11-02", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Royal Prerogative"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Exiting the European Union, pursuant to the Answer of 1 November 2016 to Question 49982, what the effect on the operation of the Ponsonby rule would be of the triggering of Article 50 of the Treaty on the Functions of the EU by the use of the prerogative.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/545", "label" : {"_value" : "Biography information for Paul Flynn"}
}
, "tablingMemberConstituency" : {"_value" : "Newport West"}
, "tablingMemberPrinted" : [{"_value" : "Paul Flynn"}
], "uin" : "51570"}
, {"_about" : "http://data.parliament.uk/resources/626506", "AnsweringBody" : [{"_value" : "Cabinet Office"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/626506/answer", "answerText" : {"_value" : " The Prime Minister is clear that she will trigger Article 50 no later than the end of March next year.<\/p> The government is disappointed by Thursday's High Court judgement, but we have no intention of letting this change our timetable for triggering Article 50. We will appeal this judgement.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4021", "label" : {"_value" : "Biography information for Chris Skidmore"}
}
, "answeringMemberConstituency" : {"_value" : "Kingswood"}
, "answeringMemberPrinted" : {"_value" : "Chris Skidmore"}
, "dateOfAnswer" : {"_value" : "2016-11-04", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/626506/answer/previousversion/18840", "answeringMember" : {"_about" : "http://data.parliament.uk/members/4021", "label" : {"_value" : "Biography information for Chris Skidmore"}
}
, "answeringMemberConstituency" : {"_value" : "Kingswood"}
, "answeringMemberPrinted" : {"_value" : "Chris Skidmore"}
}
, "questionFirstAnswered" : [{"_value" : "2016-11-04T15:09:54.613Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "53"}
, "answeringDeptShortName" : {"_value" : "Cabinet Office"}
, "answeringDeptSortName" : {"_value" : "Cabinet Office"}
, "date" : {"_value" : "2016-11-01", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Brexit"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Minister for the Cabinet Office, pursuant to the Answer of 1 November 2016 to Question 49982, which Minister will exercise the prerogative to trigger Article 50 of the Treaty on the Functions of the EU on behalf of the sovereign.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/545", "label" : {"_value" : "Biography information for Paul Flynn"}
}
, "tablingMemberConstituency" : {"_value" : "Newport West"}
, "tablingMemberPrinted" : [{"_value" : "Paul Flynn"}
], "uin" : "51394"}
], "itemsPerPage" : 10, "next" : "https://eldaddp.azurewebsites.net/answeredquestions.text?_page=1&tablingMemberConstituency=Newport+West&max-dateTabled=2016-11-15", "page" : 0, "startIndex" : 1, "totalResults" : 915, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}
| | |
| | |